Trending Topic

3d illustration of human body liver
12 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Allan A Lima Pereira, Gabriel Lenz, Tiago Biachi de Castria

Despite being considered a rare type of malignancy, constituting only 3% of all gastrointestinal cancers, the incidence of biliary tract cancers (BTCs) has been increasing worldwide in recent years, with about 20,000 new cases annually only in the USA.1–3 These cancers arise from the biliary epithelium of the small ducts in the periphery of the liver […]

Antonis Kattamis, EHA 2019 – Transfusion-dependent Thalassemia and the DEEP-2 Trial

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Jun 27th 2019

We are joined by Antonis Kattamis at the EHA conference in Amsterdam to discuss his presentation on data from the DEEP-2 trial, a multicentre, randomised, non-inferiority trial comparing the efficacy of deferiprone versus deferasirox in paediatric patients affected by transfusion-dependent haemoglobinopathies.

Questions

1. What are the complications of lifelong red blood cell transfusions in transfusion-dependent thalassaemia (TDT)? (0:05)
2. How have recent therapeutic advances affected outcomes in TDT? (0:40)
3. Could you tell us a little about your recent study of TDT patients? (1:07)
4. What were the main factors affecting efficacy of iron chelation in this group of TDT patients? (1:50)
5. What can be done to further improve outcomes in this patient population? (2:38)

Antonis Kattamis has received study support, speaker fees and is a member of the advisory board for Novartis Oncology, and has received speaker fees from Apopharma.

Filmed at the European Hematology Association (EHA) 24th congress 2019, Amsterdam, Netherlands.

touchONCOLOGY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup